Immunomedics jumps; indices slip
May 13, 2010 at 11:11 AM EDT
Immunomedics Inc. shares gain ground in early activity as shares of the biotech group jump on news that it plans to unveil clinical data for its lupus drug candidate epratuzumab at an upcoming medical meeting.
